Related Experiment Video
Updated: Feb 23, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Editor's Choice- What do small serum creatinine changes tell us about outcomes after acute myocardial infarction?
Johann Auer1, Frederik H Verbrugge2, Gudrun Lamm3
11 Department of Cardiology and Intensive Care, St Josef Hospital Braunau, Austria.
Insights
Acute kidney injury (AKI) is a common complication after percutaneous coronary intervention (PCI), increasing mortality risk. Even minor creatinine increases post-PCI are linked to worse outcomes.
Area of Science:
- Nephrology
- Cardiology
- Clinical Medicine
Background:
- Acute kidney injury (AKI) is a frequent and serious complication of percutaneous coronary intervention (PCI).
- AKI is associated with increased in-hospital mortality and other adverse outcomes.
- The incidence of AKI following PCI ranges from 3-19%, and up to 20% in primary PCI for acute myocardial infarction (AMI).
Purpose of the Study:
- To highlight the significance of acute kidney injury (AKI) as a complication of percutaneous coronary intervention (PCI).
- To discuss the impact of AKI on patient outcomes, including mortality and hospital stay.
- To address the challenges posed by varying definitions of AKI in research.
Main Methods:
- Review of recent data from the National Cardiovascular Data Registry/Cath-PCI registry.
- Analysis of patient cohorts undergoing percutaneous coronary intervention.
- Examination of different criteria used for AKI definition, including AKIN, RIFLE, and KDIGO.
Main Results:
- Approximately 7% of 985,737 patients undergoing PCI experienced AKI.
- AKI incidence can reach up to 20% in patients undergoing primary PCI for AMI.
- Even serum creatinine increases below AKI thresholds are associated with adverse outcomes like prolonged hospital stay.
Conclusions:
- Acute kidney injury (AKI) is a significant complication of PCI with serious consequences.
- Standardized definitions for AKI are crucial for accurate comparisons across studies.
- Close monitoring of renal function post-PCI is essential, as even small changes can indicate increased risk.
Abstract:
Acute kidney injury (AKI), mostly defined as a rise in serum creatinine concentration of more than 0.5 mg/dl, is a common, serious, and potentially preventable complication of percutaneous coronary intervention and is associated with adverse outcomes including an increased risk of inhospital mortality. Recent data from the National Cardiovascular Data Registry/Cath-PCI registry including 985,737 consecutive patients undergoing percutaneous coronary intervention suggest that approximately 7% experienced AKI with a reported incidence of 3-19%. In patients undergoing primary percutaneous coronary intervention for acute myocardial infarction (AMI), AKI occurs more frequently with rates up to 20% depending on patient and procedural characteristics. However, varying definitions of AKI limit comparisons of AKI rates across different studies. Recently, most studies have adopted the Acute Kidney Injury Network (AKIN) criteria for definition and classification of AKI. Beyond the AKIN criteria for AKI, other classifications such as the risk, injury, failure, loss and end-stage kidney disease (RIFLE) and kidney disease: improving global outcomes (KDIGO) criteria are used to define AKI. Notably, even small increases in serum creatinine beyond AKI may be associated with adverse outcomes including increased hospital length of stay and excess. Acute kidney injury (AKI) is a serious and potentially preventable complication of percutaneous coronary intervention (PCI). Worsening renal function is associated with adverse outcomes including a higher rate of in-hospital mortality. In patients undergoing primary PCI for acute myocardial infarction (AMI), AKI occurs up to 20% of such individuals. Varying definitions of AKI limit comparisons of AKI rates across different studies. Additionally, even small increases in serum creatinine beyond lavels meeting AKI definitions may be associated with adverse outcomes including increased hospital length of stay.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Serum Studies: Renal Function Tests
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury I: Introduction

